Literature DB >> 21300942

Antipsychotic medications and brain volume: do we have cause for concern?

David A Lewis.   

Abstract

Mesh:

Substances:

Year:  2011        PMID: 21300942     DOI: 10.1001/archgenpsychiatry.2010.187

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


× No keyword cloud information.
  12 in total

1.  Sexual dimorphic abnormalities in white matter geometry common to schizophrenia and non-psychotic high-risk subjects: Evidence for a neurodevelopmental risk marker?

Authors:  Peter Savadjiev; Larry J Seidman; Heidi Thermenos; Matcheri Keshavan; Susan Whitfield-Gabrieli; Tim J Crow; Marek Kubicki
Journal:  Hum Brain Mapp       Date:  2015-10-15       Impact factor: 5.038

Review 2.  The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics.

Authors:  Marc De Hert; Jan Sermon; Paul Geerts; Kristof Vansteelandt; Joseph Peuskens; Johan Detraux
Journal:  CNS Drugs       Date:  2015-08       Impact factor: 5.749

3.  Challenges associated with application of clinical staging models to psychotic disorders.

Authors:  Daniel H Mathalon
Journal:  Biol Psychiatry       Date:  2011-10-01       Impact factor: 13.382

Review 4.  Structural covariance networks in schizophrenia: A systematic review Part I.

Authors:  Konasale Prasad; Jonathan Rubin; Anirban Mitra; Madison Lewis; Nicholas Theis; Brendan Muldoon; Satish Iyengar; Joshua Cape
Journal:  Schizophr Res       Date:  2021-12-11       Impact factor: 4.939

5.  Insular cortex abnormalities in psychotic major depression: relationship to gender and psychotic symptoms.

Authors:  Jeremy D Cohen; Taylor Nichols; Jennifer Keller; Rowena G Gomez; Alan F Schatzberg; Allan L Reiss
Journal:  Neurosci Res       Date:  2013-03-05       Impact factor: 3.304

6.  Local gyrification index in probands with psychotic disorders and their first-degree relatives.

Authors:  Pranav Nanda; Neeraj Tandon; Ian T Mathew; Christoforos I Giakoumatos; Hulegar A Abhishekh; Brett A Clementz; Godfrey D Pearlson; John Sweeney; Carol A Tamminga; Matcheri S Keshavan
Journal:  Biol Psychiatry       Date:  2013-11-23       Impact factor: 13.382

Review 7.  Expression profiling in neuropsychiatric disorders: emphasis on glutamate receptors in bipolar disorder.

Authors:  Stephen D Ginsberg; Scott E Hemby; John F Smiley
Journal:  Pharmacol Biochem Behav       Date:  2011-10-08       Impact factor: 3.533

8.  Structural brain changes associated with antipsychotic treatment in schizophrenia as revealed by voxel-based morphometric MRI: an activation likelihood estimation meta-analysis.

Authors:  Ulysses S Torres; Eduardo Portela-Oliveira; Stefan Borgwardt; Geraldo F Busatto
Journal:  BMC Psychiatry       Date:  2013-12-20       Impact factor: 3.630

Review 9.  Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence.

Authors:  Berend Malchow; Alkomiet Hasan; Paolo Fusar-Poli; Andrea Schmitt; Peter Falkai; Thomas Wobrock
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-08-21       Impact factor: 5.270

Review 10.  Volumetric changes in the basal ganglia after antipsychotic monotherapy: a systematic review.

Authors:  B H Ebdrup; H Nørbak; S Borgwardt; B Glenthøj
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.